LOGO-Gateway-Analytical.png

The Particle Articles

Spatially-Resolved Raman Imaging for Ingredient-Specific Characterization of Combination Dry Powder Inhalers

[fa icon="calendar"] Jun 17, 2014 6:49:12 AM / by Admin

Dry Powder Inhaler AnalysisPresented at: 2014 ASSA International IWPCPS-16 Workshops
Author:
 Oksana Olkhovyk
Release Date: June 16, 2014

Since the approval of Dry Powder Inhalers containing Fluticasone Propionate and Salmeterol Xinafoate in 1999, combination inhaled therapies have dominated the COPD market. However, due to the lack of specific guidance of the Office of Generic Drugs  as to the abbreviated new drug application submission, there was very little attempts of generic manufactures to come up with bioequivalent DPI formulations until September 2013.

In this study, Raman Chemical Imaging (RCI) was shown to have a potential to address the need to accurately identify and size not only primary drug particles but also aggregates based on their unique spectroscopic properties. RCI method allows extraction of a Raman spectrum from every pixel in the image (spatial resolution approaching 350 nm can be achieved). Thus every image provides spectral and spatial information about any drug to drug or drug to excipient agglomerates that may form.

Download

 

Topics: aggregates, Blog, DPI formulations, Dry Powder Inhalers, Posters & Presentations

Admin

Written by Admin

Subscribe to Email Updates

Lists by Topic

see all

Posts by Topic

see all

Recent Posts